Do Differences in Pegylation of Interferon Alfa Matter?
published online 23 November 2009.
Refers to article:
Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
, 22 September 2009
Maria Grazia Rumi, Alessio Aghemo, Gian Maria Prati, Roberta D'Ambrosio, Maria Francesca Donato, Roberta Soffredini, Ersilio Del Ninno, Antonio Russo, Massimo Colombo
Gastroenterology
January 2010 (Vol. 138, Issue 1, Pages 108-115) Abstract |
Full Text |
Full-Text PDF (1045 KB)
Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
, 22 October 2009
Antonio Ascione, Massimo De Luca, Maria Teresa Tartaglione, Filippo Lampasi, Giovan Giuseppe Di Costanzo, Alfonso Galeota Lanza, Francesco Paolo Picciotto, Giuseppina Marino–Marsilia, Luca Fontanella, Gioacchino Leandro
Gastroenterology
January 2010 (Vol. 138, Issue 1, Pages 116-122) Abstract |
Full Text |
Full-Text PDF (269 KB)
|
Add-Ons
Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany
Reprint requests Address requests for reprints to: Stefan Zeuzem, MD, Department of Medicine 1, J.W. Goethe University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt A.M., Germany
Conflicts of interest The author discloses the following: Clinical investigator, consultant and member of speaker's bureau for Human Genome Sciences, Novartis, Roche, and Schering-Plough.
PREVIEW
Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
